ACA
LLY icon

Aptus Capital Advisors’s Eli Lilly LLY Stock Holding History

Aptus Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-200,000
Closed -$153M – 1707
2025
Q3 		$153M Sell
200,000
-200,000
-50% -$149M 1.11% 16
2025
Q2 		$312M Buy
+400,000
New +$311M 2.54% 6

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Aptus Capital Advisors's LLY Position: Q1 2026 in Review

Aptus Capital Advisors reduced its Eli Lilly (LLY) stake by 7% in Q1 2026, selling an estimated $4M and leaving 52,722 shares worth $48.5M. The position accounts for 0.38% of the portfolio, ranked #53.

Aptus Capital Advisors first reported a position in LLY in Q1 2019 and has held it in 29 quarters since. The position peaked at $60.9M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Aptus Capital Advisors held 52,722 shares of Eli Lilly worth $48.5M as of Q1 2026.
  • Aptus Capital Advisors sold 3,949 Eli Lilly shares in Q1 2026, an estimated $4M.
  • Eli Lilly made up 0.38% of Aptus Capital Advisors's portfolio in Q1 2026, its #53 holding.
  • Aptus Capital Advisors first reported a position in Eli Lilly in Q1 2019 and has held it in 29 quarters since.
  • Aptus Capital Advisors's Eli Lilly position peaked at $60.9M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Aptus Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.